Technologies related to NIDA

Custom text
Glial Cell Line-Derived Neurotrophic Factor for the Treatment of Neurodegenerative Diseases and Diabetes
Ref: NCI-E-044-2012 | Updated: 06/04/2021
A Mobile Health Platform
Ref: NCI-E-049-2015 | Updated: 06/04/2021
Human Research Information System (HuRIS)
Ref: NCI-E-266-2014 | Updated: 06/04/2021
Human Research Information System (HuRIS)
Ref: E-266-2014 | Updated: 06/04/2021
A Mobile Health Platform
Ref: E-049-2015 | Updated: 06/04/2021
Glial Cell Line-Derived Neurotrophic Factor for the Treatment of Neurodegenerative Diseases and Diabetes
Ref: E-044-2012 | Updated: 06/04/2021
Dopamine D3 Receptor Agonist Compounds, Methods of Preparation, Intermediates Thereof, and their Methods of Use
Ref: E-077-2019 | Updated: 06/04/2021
Dopamine D3 Receptor Agonist Compounds, Methods of Preparation, Intermediates Thereof, and their Methods of Use
Ref: NCI-E-077-2019 | Updated: 06/04/2021
A Most Efficient and Convergent Principal Component Analysis (PCA) Method for Big Data
Ref: E-080-2019 | Updated: 06/04/2021
A Most Efficient and Convergent Principal Component Analysis (PCA) Method for Big Data
Ref: NCI-E-080-2019 | Updated: 06/04/2021
Novel Biased Potent Opioid-Like Agonists as Improved Medications to Treat Chronic and Acute Pain
Ref: E-017-2018 | Updated: 06/04/2021
Novel Biased Potent Opioid-Like Agonists as Improved Medications to Treat Chronic and Acute Pain
Ref: NCI-E-017-2018 | Updated: 06/04/2021
Mobile Software for Substance Abuse Interventions and Behavioral Modification
Ref: E-195-2012 | Updated: 06/04/2021
Mobile Interconnected Evaluation and Learning Software
Ref: NCI-E-224-2017 | Updated: 06/04/2021
Mobile Software for Substance Abuse Interventions and Behavioral Modification
Ref: NCI-E-195-2012 | Updated: 06/04/2021
Mobile Interconnected Evaluation and Learning Software
Ref: E-224-2017 | Updated: 06/04/2021
Methods of making and using dopamine receptor selective antagonists/partial agonists
Ref: E-053-2016 | Updated: 06/04/2021
Methods of making and using dopamine receptor selective antagonists/partial agonists
Ref: NCI-E-053-2016 | Updated: 06/04/2021
Cannabinoid Receptor Meditating Compounds for Metabolic Disease
Ref: TAB-2897 | Updated: 06/04/2021
Peripherally Restricted 4,5-Dihydro-1H-Pyrazole Derivatives
Ref: E-140-2014-0 | Updated: 06/08/2021
Subscribe to Technologies related to NIDA